NIH-funded research R21 grant

Reducing lung damage from chlorine gas exposure

Official title: Electrophilic Fatty Acids Reduce Chlorine-Lung Toxicity via Inhibition of Macrophage Activation

Funded at Rutgers Biomedical and Health Sciences · NIH-11098884 · Data updated 2026-11-12

This study is looking at how some fatty acids might help protect the lungs from damage caused by chlorine gas, which can happen in accidents or during chemical attacks, and it's being tested in mice to find ways to keep our lungs healthier after such exposure.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJune 6, 2025
Project endMay 31, 2027
Funding year2025
Award (this year)$235,500
NIH project number1R21ES036419-01A1
Project IDNIH-11098884 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been exposed to chlorine gas, either through accidents or in military contexts.

Less likely to help

Patients who have not been exposed to chlorine gas or who have pre-existing severe lung conditions may not benefit from this research.

What this research studies

This research investigates how certain fatty acids can help protect the lungs from damage caused by chlorine gas, which can occur during chemical warfare or accidental exposure. The study uses a mouse model to simulate inhalation of chlorine and examines the effects of these fatty acids on lung inflammation and injury within the first 24 hours after exposure. By understanding the mechanisms involved, the research aims to identify potential treatments that could mitigate the harmful effects of chlorine on lung health.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that protect patients from severe lung damage caused by chlorine gas exposure.

How similar studies have gone: Other research has shown promise in using fatty acids to reduce inflammation and lung injury, suggesting that this approach may be effective.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Gow, Andrew J — Rutgers Biomedical and Health Sciences
  • Study coordinator: Gow, Andrew J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.